Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2020

01-04-2020 | Addiction | Viewpoint

Federal Barriers to Addressing the Opioid Epidemic

Authors: Robert A. Kleinman, MD, Nathaniel P. Morris, MD

Published in: Journal of General Internal Medicine | Issue 4/2020

Login to get access

Excerpt

In 2017, there were more than 47,000 opioid-associated overdose deaths in the United States, and the Department of Health and Human Services declared that the opioid epidemic was a public health emergency. Over the past few years, Congress has passed considerable legislation to address opioid use disorders (OUDs), including the Comprehensive Addiction and Recovery Act in 2016, the 21st Century Cures Act in 2016, and the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act in 2018. These laws provide funding to study non-narcotic pain management, monitor opioid prescribing, enhance prevention of substance use disorders, and train clinicians in addiction treatment, among other measures. …
Literature
1.
go back to reference Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse treatment Services (N-SSATS):2017. Data Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018 Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse treatment Services (N-SSATS):2017. Data Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018
3.
go back to reference Dick AW, Pacula RL, Gordon AJ, et al. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health Aff (Millwood). 2015;34(6):1028–1034.CrossRef Dick AW, Pacula RL, Gordon AJ, et al. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health Aff (Millwood). 2015;34(6):1028–1034.CrossRef
4.
go back to reference Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019; 34(6): 1039–1042.CrossRef Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019; 34(6): 1039–1042.CrossRef
6.
go back to reference Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic Distribution of Providers with a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid use Disorder: A 5- Year Update. J Rural Health. 2019 Jan; 35(1):108–112. https://doi.org/10.1111/jrh.12307. Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic Distribution of Providers with a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid use Disorder: A 5- Year Update. J Rural Health. 2019 Jan; 35(1):108–112. https://​doi.​org/​10.​1111/​jrh.​12307.
7.
go back to reference Fiscella K, Wakeman SE, Beletsky L. Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver. JAMA Psychiatry 2018;76(3):229–230.CrossRef Fiscella K, Wakeman SE, Beletsky L. Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver. JAMA Psychiatry 2018;76(3):229–230.CrossRef
8.
go back to reference Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRef Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRef
9.
go back to reference Strang J, Groshkova T, Uchtenhagen A, et al. Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. B J Psychiatry 2015;207(1):5–14.CrossRef Strang J, Groshkova T, Uchtenhagen A, et al. Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. B J Psychiatry 2015;207(1):5–14.CrossRef
Metadata
Title
Federal Barriers to Addressing the Opioid Epidemic
Authors
Robert A. Kleinman, MD
Nathaniel P. Morris, MD
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 4/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05721-5

Other articles of this Issue 4/2020

Journal of General Internal Medicine 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.